The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty

Arab Journal of Urology

Volumn 11, Issue 4, 2013, Pages 344-349

  El Azab, Ahmed S ^a   Moeen, Ahmed M ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Augmentation cystoplasty; Botulinum toxin; Overactive bladder; Refractory

Indexed keywords

BOTULINUM TOXIN A;

ACUTE ABDOMEN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUGMENTATION ILEOCYSTOPLASTY; BLADDER RECONSTRUCTION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; PATIENT SATISFACTION; POSTVOID RESIDUAL URINE VOLUME; PROSPECTIVE STUDY; QUALITY OF LIFE; UROGENITAL DISTRESS INVENTORY;

EID: 84888203268     PISSN: 2090598X     EISSN: 20905998     Source Type: Journal    
DOI: 10.1016/j.aju.2013.07.003     Document Type: Article

References (17)

1. F. Haab, and D. Castro-Diaz Persistence with antimuscarinic therapy in patients with overactive bladder Int J Clin Pract 59 2005 931 937
2. S.W. Siegel, F. Catanzaro, H.E. Dijkema, M.M. Elhilali, C.J. Fowler, and J.B. Gajewski Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention Urology 56 2000 87 91
3. H.F. Moossdorff-Steinhauser, and B. Berghmans Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review Neurourol Urodyn 33 2013 206 214
4. B. Schurch, M. Stohrer, G. Kramer, D.M. Schmid, G. Gaul, and D. Hauri Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 2000 692 697
5. P. Reyblat, and D.A. Ginsberg Augmentation cystoplasty: what are the indications? Curr Urol Rep 9 2008 452 458
6. B. Williams Patient satisfaction: a valid concept? Soc Sci Med 38 1994 509 516
7. E. Piault, C.J. Evans, D. Espindle, Z. Kopp, L. Brubaker, and P. Abrams Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire Neurourol Urodyn 27 2008 179 190
8. C.C. Thiedke What do we really know about patient satisfaction? Fam Pract Manag 14 2007 33 36
9. A.S. El-Azab, and E.J. Mascha Arabic validation of the Urogenital Distress Inventory and Adapted Incontinence Impact Questionnaires - short forms Neurourol Urodyn 28 2009 33 39
10. M.K. Margolis, K.M. Fox, A. Cerulli, R. Ariely, K.H. Kahler, and K.S. Coyne Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q) Neurourol Urodyn 28 2009 416 422
11. C. Acquadro, B. Jambon, D. Ellis, and P. Marquis Language and translations issues B. Spilker, Quality of life and pharmacoeconomics in clinical trials 2nd ed. 1995 Lippincott-Raven Philadelphia chapter 63
12. H.C. Kuo Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection Urology 72 2008 1056 1060
13. H. Schulte-Baukloh, C. Weiss, T. Stolze, J. Herholz, B. Stürzebecher, and K. Miller Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction Eur Urol 48 2005 984 990
14. D. Sussman, V. Patel, G. Del Popolo, W. Lam, D. Globe, and P. Pommerville Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity Neurourol Urodyn 32 2013 242 249
15. J.L. Bosch, C. Kelleher, P.E. van Kerrebroeck, and B. Schurch What treatment should we use if drugs fail for OAB; and, what really works after drugs? Neurourol Urodyn 29 2010 658 661
16. D.M. Schmid, P. Sauermann, M. Werner, B. Schuessler, N. Blick, and M. Muentener Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics J Urol 176 2006 177 185
17. R. Popat, A. Apostolidis, V. Kalsi, G. Gonzales, C.J. Fowler, and P. Dasgupta A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin J Urol 174 2005 984 989